


Searching News Database: Talyst
HSMN NewsFeed - 28 Jul 2026
BrainStorm Appoints Former FDA Associate Commissioner Peter J. Pitts as Executive Chairman
BrainStorm Appoints Former FDA Associate Commissioner Peter J. Pitts as Executive Chairman
HSMN NewsFeed - 7 Jul 2026
AtaCor Medical Announces First Patient Treated Globally in its ALARION-EV Pivotal Trial
AtaCor Medical Announces First Patient Treated Globally in its ALARION-EV Pivotal Trial
HSMN NewsFeed - 8 Jul 2025
Soligenix Corporate Update Letter - Key Highlights and Upcoming Milestones
Soligenix Corporate Update Letter - Key Highlights and Upcoming Milestones
HSMN NewsFeed - 13 May 2025
Hansa Biopharma appoints Maria Törnsén as Chief Operating Officer and President U.S.
Hansa Biopharma appoints Maria Törnsén as Chief Operating Officer and President U.S.
HSMN NewsFeed - 18 Apr 2025
Leidos Invests $10 Million in AI Disease Detection with University of Pittsburgh
Leidos Invests $10 Million in AI Disease Detection with University of Pittsburgh
HSMN NewsFeed - 24 Jul 2024
Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment
Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment
HSMN NewsFeed - 14 May 2024
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
HSMN NewsFeed - 21 Feb 2024
Sira Medical Wins FDA Clearance for Augmented Reality Preoperative Surgical Planning Software
Sira Medical Wins FDA Clearance for Augmented Reality Preoperative Surgical Planning Software
HSMN NewsFeed - 18 Nov 2022
Synaptogenix Announces $15 Million Private Placement with Existing Investors
Synaptogenix Announces $15 Million Private Placement with Existing Investors
HSMN NewsFeed - 8 Mar 2022
Electromedical Announces Addition of David Orn as Director of Business and Sales Development
Electromedical Announces Addition of David Orn as Director of Business and Sales Development
HSMN NewsFeed - 17 Jan 2022
CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation
CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation
HSMN NewsFeed - 4 Oct 2021
C-RAD and Accuray Sign Agreement to Enhance Radixact(R) System Breast Cancer Treatment Capabilities
C-RAD and Accuray Sign Agreement to Enhance Radixact(R) System Breast Cancer Treatment Capabilities
HSMN NewsFeed - 24 Feb 2021
Truvian Sciences Raises More Than $105 Million in Oversubscribed Series C Financing
Truvian Sciences Raises More Than $105 Million in Oversubscribed Series C Financing
HSMN NewsFeed - 8 Jun 2020
Arbor Vita Launches Open Platform COVID-19 Antibody Test Expanding Access To Higher Quality Diagnostics
Arbor Vita Launches Open Platform COVID-19 Antibody Test Expanding Access To Higher Quality Diagnostics
HSMN NewsFeed - 24 Feb 2020
Karius Secures $165 Million In Series B Funding Led By SoftBank Vision Fund 2
Karius Secures $165 Million In Series B Funding Led By SoftBank Vision Fund 2
HSMN NewsFeed - 13 Nov 2019
Otsuka Announces Retirement of President & Chief Executive Officer William H. Carson, M.D.
Otsuka Announces Retirement of President & Chief Executive Officer William H. Carson, M.D.
HSMN NewsFeed - 16 Sep 2019
Soligenix Appoints Daniel P. Ring as Vice President of Business Development and Strategic Planning
Soligenix Appoints Daniel P. Ring as Vice President of Business Development and Strategic Planning
HSMN NewsFeed - 19 Mar 2019
Centinel Spine Appoints Dirk M. Kuyper and Gregory Rainey to its Board of Directors
Centinel Spine Appoints Dirk M. Kuyper and Gregory Rainey to its Board of Directors
HSMN NewsFeed - 11 Mar 2019
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
HSMN NewsFeed - 15 Feb 2019
Phio Pharmaceuticals Appoints Gerrit Dispersyn as New Chief Executive Officer Effective March 1
Phio Pharmaceuticals Appoints Gerrit Dispersyn as New Chief Executive Officer Effective March 1
HSMN NewsFeed - 29 Jan 2019
Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
HSMN NewsFeed - 16 Nov 2018
United Imaging Healthcare Announces Appointment of World-Renowned Expert as Senior Scientific Advisor
United Imaging Healthcare Announces Appointment of World-Renowned Expert as Senior Scientific Advisor
HSMN NewsFeed - 13 Nov 2018
Sobi(TM) to Acquire Synagis(R) US Rights From AstraZeneca - Creates a Platform for Global Growth
Sobi(TM) to Acquire Synagis(R) US Rights From AstraZeneca - Creates a Platform for Global Growth
HSMN NewsFeed - 24 Jan 2018
Neuspera Medical Announces Initial Close of $26M Series B Equity Financing
Neuspera Medical Announces Initial Close of $26M Series B Equity Financing
HSMN NewsFeed - 22 Jan 2018
AVACEN Medical Device for Autistic Spectrum Disorder Behavior Management Launched in Hong Kong
AVACEN Medical Device for Autistic Spectrum Disorder Behavior Management Launched in Hong Kong
HSMN NewsFeed - 17 Jan 2018
Catalyst OrthoScience Strengthens Its Board of Directors with The Addition of Greg Rainey
Catalyst OrthoScience Strengthens Its Board of Directors with The Addition of Greg Rainey
HSMN NewsFeed - 13 Dec 2017
Audentes Therapeutics Appoints Mark A. Goldberg, M.D. to its Board of Directors
Audentes Therapeutics Appoints Mark A. Goldberg, M.D. to its Board of Directors
HSMN NewsFeed - 30 Nov 2017
Fractyl Completes $44 Million Series D Financing to Advance New Treatment for Type 2 Diabetes
Fractyl Completes $44 Million Series D Financing to Advance New Treatment for Type 2 Diabetes
HSMN NewsFeed - 17 May 2016
Catalyst Pharmaceuticals Announces Reduction in Workforce as Part of Operating Expense Management Plan
Catalyst Pharmaceuticals Announces Reduction in Workforce as Part of Operating Expense Management Plan
HSMN NewsFeed - 12 May 2016
Corvia Medical Announces CE Mark Approval And Enrollment Of First Patients In Randomized Clinical Study
Corvia Medical Announces CE Mark Approval And Enrollment Of First Patients In Randomized Clinical Study
HSMN NewsFeed - 22 Mar 2016
First FDA-Approved Medicine Manufactured Using 3D Printing Technology Now Available
First FDA-Approved Medicine Manufactured Using 3D Printing Technology Now Available
HSMN NewsFeed - 26 Feb 2016
Catalyst Pharmaceuticals Appoints Brian Elsbernd as Senior Vice President of Legal and Compliance
Catalyst Pharmaceuticals Appoints Brian Elsbernd as Senior Vice President of Legal and Compliance
HSMN NewsFeed - 17 Feb 2016
Catalyst Pharmaceuticals Receives "Refusal to File" Letter From the FDA on Its NDA for Firdapse
Catalyst Pharmaceuticals Receives "Refusal to File" Letter From the FDA on Its NDA for Firdapse
HSMN NewsFeed - 16 Feb 2016
Pharmaceutical And Biotechnology Patent Expert John Doll Joins Viropro Board
Pharmaceutical And Biotechnology Patent Expert John Doll Joins Viropro Board
HSMN NewsFeed - 16 Feb 2016
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
HSMN NewsFeed - 16 Jul 2015
Exelixis Appoints Chris Senner as Executive Vice President and Chief Financial Officer
Exelixis Appoints Chris Senner as Executive Vice President and Chief Financial Officer
HSMN NewsFeed - 5 Jan 2015
Catalyst Pharmaceuticals Appoints David D. Muth, Executive Vice President, Chief Commercial Officer
Catalyst Pharmaceuticals Appoints David D. Muth, Executive Vice President, Chief Commercial Officer
HSMN NewsFeed - 4 Sep 2014
Catalyst Pharmaceuticals Appoints David D. Muth as Executive Vice President, Corporate Development
Catalyst Pharmaceuticals Appoints David D. Muth as Executive Vice President, Corporate Development
HSMN NewsFeed - 11 Aug 2014
Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer
Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer
HSMN NewsFeed - 19 Jun 2014
Tyrogenex Raises $15M in Series D Financing from Brace Pharma, US Investment Arm of EMS S/A
Tyrogenex Raises $15M in Series D Financing from Brace Pharma, US Investment Arm of EMS S/A
HSMN NewsFeed - 17 Jun 2014
Wright Medical Group, Inc. Announces Commercial Launch of INFINITY(R) Total Ankle System
Wright Medical Group, Inc. Announces Commercial Launch of INFINITY(R) Total Ankle System
HSMN NewsFeed - 29 Jan 2014
Progenics Pharmaceuticals Announces the Appointment of Karen Ferrante, M.D. to Its Board of Directors
Progenics Pharmaceuticals Announces the Appointment of Karen Ferrante, M.D. to Its Board of Directors
HSMN NewsFeed - 13 Aug 2013
Vidacare Corporation launches the T.A.L.O.N.(TM) Intraosseous Vascular Access System
Vidacare Corporation launches the T.A.L.O.N.(TM) Intraosseous Vascular Access System
HSMN NewsFeed - 12 Jun 2013
RTI Biologics(R) Announces Agreement to Acquire Pioneer(R) Surgical Technology
RTI Biologics(R) Announces Agreement to Acquire Pioneer(R) Surgical Technology
HSMN NewsFeed - 22 Oct 2012
DARA BioSciences Launches Soltamox(R), First and Only Liquid Version of Tamoxifen Citrate
DARA BioSciences Launches Soltamox(R), First and Only Liquid Version of Tamoxifen Citrate
HSMN NewsFeed - 2 Dec 2011
Catalyst Pharmaceutical Partners Promotes Alicia Grande to Vice President and Chief Financial Officer
Catalyst Pharmaceutical Partners Promotes Alicia Grande to Vice President and Chief Financial Officer
HSMN NewsFeed - 14 Nov 2011
Catalyst Pharmaceutical Partners Appoints Richard P. Rieger as Vice President, Commercial Operations
Catalyst Pharmaceutical Partners Appoints Richard P. Rieger as Vice President, Commercial Operations
HSMN NewsFeed - 12 May 2011
Varian Medical Systems Makes Equity Investment and Obtains Option to Purchase Augmenix
Varian Medical Systems Makes Equity Investment and Obtains Option to Purchase Augmenix
HSMN NewsFeed - 25 Jan 2011
Catalyst Pharmaceutical Partners Promotes Steven R. Miller, Ph.D. to Chief Operating Officer
Catalyst Pharmaceutical Partners Promotes Steven R. Miller, Ph.D. to Chief Operating Officer
HSMN NewsFeed - 21 Dec 2010
TearScience Wins SEBIO Award for Securing $44.5 Million in Venture Funding in 2010
TearScience Wins SEBIO Award for Securing $44.5 Million in Venture Funding in 2010
HSMN NewsFeed - 14 Jun 2010
Cardiva Medical, Inc. Announces Appointment of Charles Maroney, President and Chief Executive Officer
Cardiva Medical, Inc. Announces Appointment of Charles Maroney, President and Chief Executive Officer
HSMN NewsFeed - 14 Jun 2010
aTyr Pharma Appoints Catharine E. Johnson As Senior Vice President of Business Development
aTyr Pharma Appoints Catharine E. Johnson As Senior Vice President of Business Development
HSMN NewsFeed - 19 Feb 2010
In Honor of American Heart Month, TeleHealth Services and Local Hospitals Ask Patients to Watch More TV
In Honor of American Heart Month, TeleHealth Services and Local Hospitals Ask Patients to Watch More TV
HSMN NewsFeed - 13 Jan 2010
The Foundry Announces Completion of Series A Financing for Twelfth Company
The Foundry Announces Completion of Series A Financing for Twelfth Company
HSMN NewsFeed - 28 Oct 2009
MolecularMD Establishes New Operations Facility to Support Growth in Personalized Cancer Medicine Business
MolecularMD Establishes New Operations Facility to Support Growth in Personalized Cancer Medicine Business
HSMN NewsFeed - 30 Sep 2009
ThermalTherapeutic Systems Completes $2.75 Million Series A Financing With Originate Ventures
ThermalTherapeutic Systems Completes $2.75 Million Series A Financing With Originate Ventures
HSMN NewsFeed - 2 Apr 2009
RXi Pharmaceuticals Announces an Addition, Promotions Among Senior Management Team
RXi Pharmaceuticals Announces an Addition, Promotions Among Senior Management Team
HSMN NewsFeed - 12 Mar 2009
Jon R. Cohen, M.D., Named Senior Vice President and Chief Medical Officer at Quest Diagnostics
Jon R. Cohen, M.D., Named Senior Vice President and Chief Medical Officer at Quest Diagnostics
HSMN NewsFeed - 19 Feb 2009
Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
HSMN NewsFeed - 28 Jan 2009
The Foundry Announces New Partners and Completion of Series A Financing for Eleventh Company
The Foundry Announces New Partners and Completion of Series A Financing for Eleventh Company
HSMN NewsFeed - 26 Jan 2009
Cleveland Clinic and Mubadala Healthcare Name CEO of Cleveland Clinic Abu Dhabi
Cleveland Clinic and Mubadala Healthcare Name CEO of Cleveland Clinic Abu Dhabi
HSMN NewsFeed - 9 Sep 2008
MicroMed Cardiovascular Purchased and Taken Private by Artificial Heart CEO and Some SynCardia Investors
MicroMed Cardiovascular Purchased and Taken Private by Artificial Heart CEO and Some SynCardia Investors
HSMN NewsFeed - 29 Jul 2008
ArunA Biomedical Names William T. Sharp President and Chief Executive Officer
ArunA Biomedical Names William T. Sharp President and Chief Executive Officer
HSMN NewsFeed - 9 Jan 2008
Ortec Shareholders Approve Corporate Name Change to Forticell Bioscience, Inc.
Ortec Shareholders Approve Corporate Name Change to Forticell Bioscience, Inc.
HSMN NewsFeed - 11 Dec 2007
Organogenesis, Inc. Signs Memorandum of Understanding with Chinese Regenerative Medicine Company
Organogenesis, Inc. Signs Memorandum of Understanding with Chinese Regenerative Medicine Company
HSMN NewsFeed - 22 Oct 2007
AVANT Immunotherapeutics, Inc. and Celldex Therapeutics, Inc. Announce Merger Agreement
AVANT Immunotherapeutics, Inc. and Celldex Therapeutics, Inc. Announce Merger Agreement
HSMN NewsFeed - 4 Oct 2007
Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc.
Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc.
HSMN NewsFeed - 27 Sep 2007
Central Texas Health System Strengthens Processes for Contracting Through Premier's Breakthrough Series
Central Texas Health System Strengthens Processes for Contracting Through Premier's Breakthrough Series
HSMN NewsFeed - 7 Sep 2007
RXi Pharmaceuticals Names Life Science Veteran Stephen J. DiPalma Chief Financial Officer
RXi Pharmaceuticals Names Life Science Veteran Stephen J. DiPalma Chief Financial Officer
HSMN NewsFeed - 9 Aug 2007
Newly Created Hemosol BioPharma Inc. on the Hunt for Partnership, Licensing and Acquisition Targets
Newly Created Hemosol BioPharma Inc. on the Hunt for Partnership, Licensing and Acquisition Targets
HSMN NewsFeed - 1 Aug 2007
American Academy of Dermatology Says New Technologies Tighten Skin From Head to Toe Without Surgery
American Academy of Dermatology Says New Technologies Tighten Skin From Head to Toe Without Surgery
HSMN NewsFeed - 11 Jul 2007
Ventana's Board Unanimously Rejects Roche's Unsolicited Tender Offer as Inadequate
Ventana's Board Unanimously Rejects Roche's Unsolicited Tender Offer as Inadequate
HSMN NewsFeed - 4 Jul 2007
Circassia Announces the Appointment of Sir Richard Sykes as Chairman of the Board
Circassia Announces the Appointment of Sir Richard Sykes as Chairman of the Board
HSMN NewsFeed - 18 Jun 2007
StemCells, Inc. Announces Important Milestone in Batten Disease Clinical Trial
StemCells, Inc. Announces Important Milestone in Batten Disease Clinical Trial
HSMN NewsFeed - 3 Jun 2007
QIAGEN and Digene Announce Merger Creating Market and Technology Leader In Molecular Diagnostics
QIAGEN and Digene Announce Merger Creating Market and Technology Leader In Molecular Diagnostics
HSMN NewsFeed - 21 May 2007
Hologic and Cytyc to Merge Creating a $10 Billion Global Leader in Women's Healthcare
Hologic and Cytyc to Merge Creating a $10 Billion Global Leader in Women's Healthcare
HSMN NewsFeed - 18 May 2007
KV Pharmaceutical Company Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
KV Pharmaceutical Company Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
HSMN NewsFeed - 12 Jan 2007
Catalyst Pharmaceutical Partners, Inc. Adds Thomas Kosten, M.D. to Its Scientific Advisory Board
Catalyst Pharmaceutical Partners, Inc. Adds Thomas Kosten, M.D. to Its Scientific Advisory Board
HSMN NewsFeed - 10 Nov 2006
Talyst Receives $20 Million Funding to Accelerate Growth of Medication Safety Systems
Talyst Receives $20 Million Funding to Accelerate Growth of Medication Safety Systems
HSMN NewsFeed - 17 Oct 2006
EXACT Sciences Corporation Announces Restructuring and Third Quarter 2006 Conference Call
EXACT Sciences Corporation Announces Restructuring and Third Quarter 2006 Conference Call
HSMN NewsFeed - 11 Sep 2006
Perrigo Announces Joseph C. Papa as New CEO; David T. Gibbons to Remain as Chairman
Perrigo Announces Joseph C. Papa as New CEO; David T. Gibbons to Remain as Chairman
HSMN NewsFeed - 25 May 2006
Antipodean Pharmaceuticals Initiates Phase 2 Trial in Parkinson's Disease
Antipodean Pharmaceuticals Initiates Phase 2 Trial in Parkinson's Disease
Additional items found! 75
Members Archive contains
75 additional stories matching:
Talyst
(Password required)
Talyst
(Password required)
